Skip to content

DOKTER DEWITTE

Active
Private limited companyfounded 2020active for 5 yearsHertog Jan I-straat 1, 3010 Leuven, BelgiumKBO/BCE: BE 0758.367.180
Summary

DOKTER DEWITTE has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10,000 and a net result of €53,831. Equity is shrinking by about 41% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 14% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

History

DOKTER DEWITTE was incorporated on 12 November 2020 as a private limited company.1 Total assets rose from €46,401 in 2020 to €94,434 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
01-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
05-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
30-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
03-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Highest result from 2020 to 2025net €55,469 ▲16.2%
Net result €55,469, the highest in the series.
31-12
Financial Equity above €100,000equity €111,302 ▲96.5%
2 profitable years in a row build equity to €111,302.
27-06
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Back to profitnet €47,740
Net result €47,740 after one loss-making year.
01-07
NBB filing Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.